inducers of the peripheral nervous system-the products of the achaete-scute genes (15)-bind in vitro to the same muscle-specific sequences, as well as to related immunoglobulin enhancer sequences (4). Thus, it seems paradoxical that different bHLH proteins apparently can bind similar DNA sequences and yet act in vivo on tissue-restricted sets of genes (4, 5) . It is therefore crucial to determine whether there might be important differences in the sequence-specificity with which MyoD and other bHLH proteins recognize DNA. In addition, very little is known about how the basic regions of bHLH proteins contact DNA. This issue is of particular importance for MyoD because its basic region seems to mediate not only DNA binding, but also the subsequent transcriptional activation of muscle-specific genes (5) .
A number of biochemical assays that involve protection of bound DNA or interference with the ability to bind DNA have provided important information as to how and where specific proteins bind. Mutational analyses have revealed much about the sequence specificity of binding, but a comprehensive study requires that a large number of mutants be generated and separately characterized. More recently, the range of information available from mutational analyses has been expanded by use of random-sequence mutagenesis (16, 17) . For example, sequences within a protein-binding site (16) or protein (17) that function in a biological or biochemical assay are selected from a pool of random DNA sequence. Such studies can yield significant information about protein-binding sites in DNA but, again, require isolation and sequencing of a large number of mutants.
We have now developed a strategy for studying the DNA sequence specificity of protein-DNA binding that is based on random-sequence selection, but also allows simultaneous analysis of bound sequences as a population (Fig. 1A) . From oligonucleotides in which specific binding site positions are random in sequence, those that are bound are isolated in an electrophoretic mobility shift assay (EMSA), amplified by the polymerase chain reaction (PCR), reiteratively re-bound and reamplified, and finally sequenced directly as a pool. The nucleotide sequence patterns of these "selected and amplified binding sites" (SAAB's) provide a characteristic "imprint" of protein binding. We have used SAAB imprints to compare and contrast the sequence-preferences of DNA binding by MyoD and E2A homo-and heterooligomers. Our results indicate that these different protein species preferentially bind the consensus CA--TG motif, but select different sequence patterns at internal and surrounding positions. Their SAAB imprints suggest that in bHLH complexes individual protomers recognize half-sites on the DNA and, therefore, that the combinatorial interactions between these proteins can, in fact, define new binding preferences. Subtle nucleotide sequence differences among bHLH protein-binding sites may thus be more important than previously realized. In addition, we have shown that proteins produced by reticulocyte lysates programmed with in vitro transcribed RNA can yield high-quality SAAB imprints, opening up the possibility that proteins mutagenized in vitro can be rapidly screened by this type of analysis. CA--TG can define the other half. The binding templates were based on a site in the muscle creatine kinase (MCK) enhancer (11) (Fig. 1B) that is required for its activation and to which MyoD and E2A protein complexes bind in vitro (4-6). Dimers of this site specifically direct cotransfected MyoD-dependent expression of a reporter gene in a variety of cell types (18) . In the DI and D2 templates, one-half of the consensus and core is specified and the other half is random (Fig. 1B) . In the D2 template, position +4 is also random because methylation-interference studies suggest that this position is contacted by MyoD and E12-MyoD oligomers (4, 6) (E12 and E47 are differentially spliced E2A proteins).
Bacterially produced glutathione-S-transferase-MyoD fusion protein (GluMyoD) binds to Dl and D2 to a proportionally much smaller extent than to the wild-type MCK site ( Fig. 2A) , which suggests that only a subset of D1 or D2 is bound with high affinity. The Dl-and D2-GlyMyoD SAABs (Fig. 2B) show preferences for CA and TG at positions -3, -2 and +2, +3, respectively, and the D2-GluMyoD sequence reveals an additional T preference at position +4. These preferences are derived from only one round of EMSA selection and at most positions are not absolute, but they nevertheless confirm the importance of the CA--TG motif (19) .
Binding of MyoD and E2A proteins with different sequence preferences within the context of the CA--TG consensus. We used the D3 template, in which the CA--TG consensus is specified but surrounding positions are random in sequence (Fig. 1B) , to determine whether bHLH proteins have additional binding sequence preferences. Binding of the MCK, D2, and D3 templates by various complexes of MyoD and E12 and E47 (2), which were synthesized by in vitro translation, was investigated (Fig. 3, A and  B) . With the MCK template, multiple complexes that consisted of dimers and higher-order oligomers were formed in most cases (5). A much smaller relative fraction of the D2 and D3 templates were bound, and significant background signal was present in each lane.
However, the SAAB's derived from three successive rounds of selection and amplification (Fig. 3C) were bound by their respective complexes to a greater relative extent, and with less nonspecific background. Each SAAB was generated by successive selection for binding by a single complex (Fig. 3B) but was bound by the same set of multimeric complexes evident in Fig. 3B (that is, the initial binding pattern is serially regenerated), indicating that the members of each set of complexes can bind the same DNA sequences. Some of these SAAB's were also bound by specific but unidentified factors present in the reticulocyte lysate (Fig. 3C, lanes 3 , 5, 9, and 13). Binding by a lysate factor is most striking in the D3-E12 SAAB (Fig. 3C, lanes 3 and 4) ; the proportion of binding is the same in the control lane, which suggests that this SAAB was derived primarily from the lysate factor. These SAAB sequences were determined (Fig. 3 , D and E) and compiled (Fig. 4) . Under our experimental conditions, the sequence preferences derived from the first selection round (20)-when the proteins were in excess of their potential sites and all possible sequences were bound-were usually less specific than those derived from the third round (Fig. 3, D and E). After multiple selection rounds, when potential binding sites appear to be in excess and only a fraction of the labeled templates are bound (Fig. 3C) , it is likely that only the binding sequences with the highest affilities are selected. Hence, this technique, as we have applied it, really provides the most preferred binding sites, and it would be unwise to conclude that a given sequence necessarily cannot bind with reasonable affinity if its sequence does not match the preferred one. Clearly, the technique can be used to detect sequences that bind with less affinity if the protein is maintained in excess at each round of seletion; however, this is difficult to achieve with in vitro translated products.
When confronted with the symercal arrangement of random (Fig. 3D , labeled as lysate), except for a higher level of nonspecific background. This finding further indicates that the D3-E12 SAAB's were derived primarily from sequence-specific binding by a reticulocvte lysate factor, which predominates over binding by the translated E12. Binding by this lysate factor was also apparent to some extent in the E47-M4yoD and E12-MyoD heterooligomer SAAB's (Fig. 3, D and E) , as indicated by a GT pair at -1 and + 1 (Fig. 4) (Fig. 3E and Fig. 4 ) but otherwise bind asymmetrically. At positions -1 and +1, both select an asymmetrical CC pair (Fig. 3, D and E, and Fig. 4) . Most strikingly, their preferences at -4 and -5 are almost identical to those of the E47 homooligomer, and at +4 and +5 are similarly close to those of MyoD homooligomers (Fig. 3, D and E) . This similarity to the corresponding MyoD preference at + 5 is especially apparent in the D3-E12-MyoD SAAB's (23). The sequence preference patterns of MyoD and E47 homooligomers at positions -4 and +4 and -5 and +5 thus give a diagnostic "imprint' of binding by those particular proteins, and indicate that in heterooligomeric complexes the respective DNA-binding regions of the MyoD and E2A proteins bind to distinct half-sites (Fig. 4) . This suggests that the basic regions from each monomer do not interdigitate in some way to present a common binding surface; instead, each seems to have its own target. The asymmetry of these heterooligomer imprints indicates further that these complexes are binding in a defined orientation relative to the rest of the template, and thus that base pairs more distal to the core than positions -5 and + 5 are having a significant effect on binding. MyoD half-sites are present in muscle-specific regulatory regions. Of 22 CA--TG motifs present in muscle-specific regulatory regions that were examined (24), nucleotides that meet the criteria for a MyoD half-site are present at -5 and -4 or + 4 and + 5 in 11 (50 percent), including MCK. In contrast, among 31 such sites present in regulatory regions of surveyed non-muscle cellular genes (24), these half-sites are present in only four (13 percent), or at about the statistically predicted frequency of one in eight. These observations are more striking if it is considered that the musclespecific sites that do not fit the MyoD consensus might be recognized by the products of other myogenic determination genes-such myogenin, Myf5, or MRF4-Myf6-herculin (8, 25)-that could potentially have slightly different binding specificities; moreover, some of these sites might not be used by muscle-specific factors. Of potential additional significance, a GCTG motif that frequently overlaps or flanks muscle-specific CA--TG elements (6, 24) is part of the CAGCTG consensus identified by the MyoD homooligomer SAAB imprints (Fig. 4) .
Applications of the SAAB imprint assay. By combining the power of random-sequence selection with pooled sequencing, the SAAB imprint assay makes possible simultaneous screening of a large number of binding site mutants. This technique allows identification of sites that bind with high relative affinity, because competition is inherent in the protocol. It can also identify site positions that are neutral, or specific bases that can interfere with binding, such as a T at -4 in the E47 half-site (Fig. 4) . When several bases are selected at more than one position in a SAAB imprint (for example, C or G at positions -1 and +1 in the E47 consensus), some may actually be coupled with each other in the actual preferred sites. This can be investigated by cloning and sequencing individual selected templates or by judicious choice of an alternative random oligonucleotide template. In the above example, the D2-E47 SAAB clearly shows that the C at + 1 is coupled to the C at -1 as, by inference, are G and G (22). In addition, SAAB imprints can complement and extend data from footprinting, binding-interference, and other biochemical assays of protein-DNA interaction.
We envision that this assay will be useful in three general situations: (i) when both the binding site and the protein are known and available; (ii) when only a.consensus binding site is available and the binding protein is not; and (iii) when the protein is available, but the binding site is unknown. Our initial efforts apply primarily to the first situation, where we establish this as a useful technique by focusing on the interactions of MyoD and E2A homo-and heterooligomers with a consensus CA--TG sequence. In doing so, we have shown that in vitro-translated proteins can be used and, hence, that mutant proteins can be rapidly analyzed. For the second category, we have detected activities in reticulocyte lysates and in nuclear extracts from several cell types (20) that bind to CA--TG sites, thus demonstrating a general usefulness of this technique for identifying factors that bind to variations of a known consensus. Finally, in most cases the third category will require an approach that is modified from the one described here. When the binding site is not known, the number of random nucleotide positions in the template must be large. If, as is likely, this number turns out to be larger than the actual binding site, then a "phasing" problem arises because the binding site can begin at many positions along the random nucleotide stretch and direct sequencing will not give a unique sequence. Cloning and sequencing of individual reiteratively selected and amplified binding species would therefore be in order. es (4, 5, 27) . Hence, why are muscle-specific or immunoglobulin genes not activated in nerve cells? Moreover, as indicated above, other cell types seem to contain protein species capable of recognizing the CA--TG consensus (10, 13), indicating that the problem of specificity is even more complex. Consideration of the second paradox might offer some resolution. When the basic region of MyoD is replaced by that of an achaete-scute product, the resulting chimeric protein can bind muscle-specific enhancers but fails to activate muscle-specific genes in vivo (5). These results suggested that some combined property of the DNA-binding site and the bound basic region results in activation of muscle-specific transcription, and led to the prediction that DNA sequences exist that could support E2A-MyoD binding but not support activation of a MyoDresponsive gene (5). Analogous sites that support binding but not activation have been identified for other transcriptional regulatory proteins (5). The SAAB imprint technique has provided a spectrum of binding sites that can be used to test this prediction.
Our results have also provided some general insights into the structural aspects of DNA binding by bHLH proteins. The palindromic character of the CA--TG motif indicates a degree of structural symmetry of protein-DNA contact, but the otherwise asymmetrical preferences of E12-MyoD and E47-MyoD heterooligomers suggest that in these complexes the respective basic regions each bind to a half-site on the DNA. The respective selected half-sites for MyoD and E2A proteins are nearly the same in the various homo-and heterooligomeric complexes, even though heterooligomeric complexes generally bind with significantly higher affinities (4, 5) (Fig. 3C ). Although other explanations are possible, these differences in binding could reflect the relative efficiencies of dimerization. Our findings thus predict, for example, that MyoD and E12 proteins dimerize less efficiently with themselves than with each other. An unexpected result from our analysis is the preferred binding of putatively symmetrical E47 homooligomers to asymmetrical sites. Whether binding to these sites induces or stabilizes an asymmetrical conformation of E47 awaits direct verification.
The bHLH proteins that have been shown to bind a CA--TG consensus site contain a conserved Glu-Arg-X-Arg (or Glu-Lys-XArg) sequence (where X represents any amino acid) in the basic region at exactly the same position vis-a-vis the HLH dimerization domain (3, 10, 28). In both homo-and heterooligomers, the Glu-Arg-X-Arg sequence within each monomer might, in fact, directly contact the conserved CA and TG residues, respectively. By analogy, only two amino acids are conserved between the DNArecognition helices of lambda phage cl repressor and cro; these residues make contact with the only two nucleotides that are absolutely conserved among all of the half-sites within the six partially palindromic binding sites for these protein dimers (29). The other bases in these recognition sites vary, so that they are recognized by cl and cro with different relative affinities that have functional consequences (29). Perhaps analogous principles operate in recognition of the CA--TG consensus by bHLH proteins.
Note added in proof Techniques that are similar to the SAAB imprint assay have been reported since submission of this manuscript (37).
